From: Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase
Characteristic | Total (n=57) | Severe (n=17) | Non-severe (n=40) | p Value |
---|---|---|---|---|
Age, year | 46.72 (13.78) | 52.53 (13.30) | 44.25 (13.3) | 0.031 |
Male gender, No | 26 (45.6%) | 12 (70.6%) | 14 (35.0%) | 0.014 |
BMI, kg/m2 | 23.99 (3.55) | 25.54 (3.43) | 23.33 (3.42) | 0.103 |
Pre-existing medical illness | 21 (36.8%) | 7 (41.2%) | 14 (35%) | 0.658 |
LOS, days | 20.89 (7.22) | 20 (16-24) | 19 (15-24) | 0.834 |
WBC, ×10^9/L | 5.01 (1.50) | 4.47 (1.35) | 5.24 (1.52) | 0.076 |
lymphocyte count, ×10^9/L | 1.60 (0.55) | 1.30 (0.35) | 1.72 (0.58) | 0.008* |
CRP, mg/dL | 9.69 (13.77) | 22.65 (18.19) | 4.18 (5.66) | <0.001* |
LDH, U/L | 175.47 (43.60) | 201.94 (43.96) | 164.22 (38.76) | 0.002* |
CK, U/L | 91.95 (118.16) | 133.18 (209.4) | 74.42 (31.69) | 0.235 |
Lactic acid, mmol/L | 1.59 (0.61) | 1.51 (0.65) | 1.62 (0.59) | 0.511 |
PaO2 to FiO2 ratio, mmHg | 308.67 (94.40) | 198.47 (97.04) | 355.51 (37.23) | <0.001* |
TSS on the worst chest CT scan | 4.28 (4.26) | 8.59 (4.15) | 2.45 (2.73) | <0.001* |
TSS on chest CT on the 14th day after discharge | 1.75 (2.23) | 3.94 (2.33) | 0.83 (1.39) | <0.001* |
glucocorticoids use | 16 (28.1%) | 11 (64.7%) | 5 (12.5%) | <0.001* |
Total methyprednisolone dosage, mg | 213.75 (323.87) | 289.09 (370.4) | 48.0 (17.89) | 0.019* |